0 TSX News - November 14, 2024Freehold Royalties Announces Amendment to Credit Facilities AgreementCALGARY, Alberta, Nov. 14, 2024 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) announces an amendment to […]Read More
0 NASDAQ Companies - November 14, 2024Innovative Baker Hughes Emissions Abatement Solution Chosen to Reduce Routine Flaring at SOCAR’s Baku Oil RefineryBaker Hughes to deliver integrated gas recovery and hydrogen sulfide (H2S) removal system Solution expected to recover flare gas equivalent […]Read More
0 NYSE Companies - November 14, 2024Getty Images Unlocks Premium Creative Content for TikTok AdvertisersA Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) […]Read More
0 NASDAQ Companies - November 14, 2024Hollywood Favorite, Fatburger, Opens 10th Location in TexasBeloved Burger Chain Continues to Sizzle in the Lone Star State with Latest San Antonio Area Opening LOS ANGELES, Nov. […]Read More
0 NYSE Companies - November 14, 2024Toll Brothers Announces New Luxury Home Community Now Open in Flower Mound, TexasFLOWER MOUND, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, is […]Read More
0 NASDAQ Companies - November 14, 2024Nayax to Showcase Tigapo’s Innovative Interactive Amusement Solution at IAAPA Expo 2024, Now with AI Chatbot for OperatorsHERZLIYA, Israel, Nov. 14, 2024 (GLOBE NEWSWIRE) — NayaxLtd. (Nasdaq: NYAX; TASE: NYAX) – a global commerce enablement and payments […]Read More
0 NASDAQ Companies - November 14, 2024Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the KneePARSIPPANY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of […]Read More
0 NASDAQ Companies - November 14, 2024Corvus Pharmaceuticals Announces New Preclinical Data Highlighting Potential of Soquelitinib to Treat Systemic SclerosisAdds to growing body of evidence supporting the potential of ITK inhibition as a novel therapeutic for the treatment of […]Read More